China Literature Limited reported to the Hong Kong Stock Exchange that it repurchased 600,000 ordinary shares on 25 June 2026. The on-market purchases were executed at prices between HKD 18.76 and HKD 19.28 per share, for a total consideration of HKD 11.41 million, implying an average price of roughly HKD 19.02.

Since activation of the current buy-back mandate on 2 June 2026, the company has acquired an aggregate 6.80 million shares, equivalent to 0.67% of the 1.02 billion shares outstanding when the mandate was granted. The cumulative cash outlay stands at approximately HKD 0.14 billion, translating into a volume-weighted average purchase cost of about HKD 21.18 per share.

All 6.80 million shares have been earmarked for cancellation but remained uncancelled as of 25 June 2026; accordingly, the registered share capital was unchanged at 1.02 billion shares with no treasury shares on record.

Under the shareholder authorisation, China Literature is permitted to repurchase up to 102.15 million shares. Following the transactions to date, around 95% of that limit remains available. In line with Hong Kong listing rules, the company is subject to a 30-day moratorium on issuing new shares until 25 July 2026.